Agilent In Situ Hybridization Probes
Agilent Technologies released a range of new probes for in situ hybridization. The probes address the need to cleanly and accurately interpret data from fluorescence in situ hybridization and chromogenic in situ hybridization, Agilent said. The new Agilent SureFISH probes include Break-Apart: MALT1, BCL2, BCL6, CCND1, MYC, IGH; and Dual Fusion: IGH/CCND1, IGH/MYC, and IGH/BCL2. The new CISH probes include (ASR) EBER RNA CISH and Kappa and Lambda mRNA CISH probes.
Biocept CEE-Sure Blood Collection Tubes
Biocept has launched its CEE-Sure blood collection tubes for research use only. Under a previously-announced distribution agreement, the tubes are being internationally distributed through VWR, a leading global provider of product and service solutions to laboratory and production customers. Specimen types that can be transported include blood, cerebrospinal fluid, sputum, and fluid obtained from pleural effusion. The tubes employ a patented media that inhibits cell clumping, preventing clogging of microfluidics devices used in circulating tumor cell analyses. They can also preserve high-quality circulating cfDNA for advanced molecular testing applications like non-invasive prenatal testing and detection of gene mutations in cancer.
Molecular Health Guide Version 3.0
Molecular Health has released version 3.0 of its Molecular Health Guide software platform for precision medicine. According to the company, the new release offers improved biomarker classification and now supports Human Genome Variation Society nomenclature, allowing users to incorporate other diagnostic test results into MH Guide reports, which combine patient-specific molecular data with biomedical knowledge to assist physicians in choosing treatments. MH Guide is registered as an in vitro diagnostic device in the European Union.
For more new products and services, please visit the New Products page on our website.